http://www.einstein.yu.edu - Vern Schramm, Ph.D., professor and chair of biochemistry, discusses how Einstein’s proposed Center for Molecular Therapeutics and Drug Discovery will help propel research findings into clinical applications. This will be crucial for drug therapies that large drug companies do not typically invest in, such as those for tuberculosis and malaria. This edition of Einstein On, a research and medicine podcast, is hosted by Gordon Earle, associate dean for communications and public affairs